SEP 10, 2019 12:36 PM PDT

Early onset colorectal cancer on the rise

New research from the American Cancer Society and recently published in Gut shows that colorectal cancer in young adults is on the rise in high-income countries. The study was conducted by Rebecca Siegel, MPH, and her colleagues.

Siegel’s team of researchers was interested in finding out more about early onset colorectal cancer on a global scale. To do so, they used cancer incidence registries to look at data for colorectal cancer occurrence in adults under 50 versus adults over 50. Their analysis combined data for 43 countries covering six continents.

Because of the general trend that we are seeing globally of declining or stable numbers of colorectal cancer diagnoses in adults over 50, the researchers were surprised to find the opposite happening in a significant number of countries for adults under 50. As they report in the study:

“In nine countries, specifically, the rise in early-onset CRC was in contrast to trends in those 50 and older, which were either dropping (Australia, New Zealand, Canada, Germany, and United States) or stable (Denmark, Slovenia, Sweden, and United Kingdom). In all but one of these countries with long-term data, the uptick in early-onset CRC began in the mid-1990s. In addition, in three countries (Cyprus, Netherlands, and Norway) where incidence rose in both younger and older age groups, the increase in young adults was twice as steep as that in older adults and also began in the mid-1990s.”

Why would more younger people be receiving more diagnoses of colorectal cancer across the board? The authors surmise that changes in early-life exposures are increasing the risk of colorectal cancer (CRC).

"These patterns potentially signal changes in early-age exposures conducive to large bowel carcinogenesis and highlight an urgent need for research to explore the potentially unique etiology of young-onset CRC," said Ms. Siegel. "Although the absolute risk of CRC in adults younger than 50 years is low relative to older adults, disease trends in young age groups are a key indicator of recent changes in risk factor exposures and often foreshadow the future cancer burden."

Why is early onset CRC on the rise? Photo: Pixabay

The authors urge that more investigation into this topic is necessary in order to understand the long-term trends at play. Because colorectal cancer is the third most commonly diagnosed cancer worldwide, constructing a fuller image of CRC and early onset CRC is crucial in mitigating premature morbidity. Already CRC is on the decline in those over 50, assumedly because of improved screening; perhaps, the authors say, these screenings should extend to those under 50 as well.

Sources: Science Daily, Gut

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JAN 07, 2020
Clinical & Molecular DX
JAN 07, 2020
Saliva Test for Early Detection of Mouth and Throat Cancer
“OPC is one of the fastest rising cancers in Western countries due to increasing HPV-related incidence, especially in younger patients. It is paramou...
JAN 15, 2020
Drug Discovery & Development
JAN 15, 2020
Acid-Reflux Drugs May Negatively Impact Breast Cancer Survivors
Many of us have taken some form of an acid-reflux drug—especially after a meal that causes discomfort. However, now researchers are indicating that s...
JAN 21, 2020
Cannabis Sciences
JAN 21, 2020
Medical Marijuana Ineffective for Long Term Pain Management
Medicinal cannabis may not as effective as once thought as a solution for sleep problems for those with chronic pain in the long run, according to new find...
JAN 23, 2020
Cancer
JAN 23, 2020
The role of circular RNA in melanoma
New research published in the journal Cancer Cell investigates the role of circular RNAs in the spread of melanoma. Melanoma is a particularly aggressive c...
FEB 13, 2020
Cancer
FEB 13, 2020
Can Ebola help treat glioblastomas?
You might want to sit down for this. New research published in the Journal of Virology has named a surprising new ally to brain tumors: Ebola. Yes, yo...
FEB 11, 2020
Cancer
FEB 11, 2020
Could we be over-diagnosing cancer?
Roughly one in every two people are estimated to receive a cancer diagnosis at some point in their lives, but are all of those diagnoses valid? New researc...
Loading Comments...